Northwire Canada EditionFriday, July 10, 2026
Sign inSubscribe
Northwire
⌕
S 0.165 +37.5% NNX 0.035 +0.0% ABX 52.05 −0.3% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.32 +12.1% TUNG 1.73 +2.4% LGO 1.00 −3.4% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.50 +1.1% SGZ 0.040 −11.1% GRSL 0.307 −3.9% DEX 0.380 −1.3% WMS 0.040 +0.0% S 0.165 +37.5% NNX 0.035 +0.0% ABX 52.05 −0.3% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.32 +12.1% TUNG 1.73 +2.4% LGO 1.00 −3.4% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.50 +1.1% SGZ 0.040 −11.1% GRSL 0.307 −3.9% DEX 0.380 −1.3% WMS 0.040 +0.0%
Earnings

Rubicon Organics Reports 2025 Financial Results

By The Northwire Desk — AI Analysis Mar 24, 2026 · 07:30 ROMJ · 0.49 Rubicon Organics Inc.
ROMJ · Price

Executive Summary

  • Rubicon Organics reported record 2025 net revenue of $59.5 M (up 22% YoY) and a Q4 2025 revenue of $16.5 M (up 16% YoY).
  • Adjusted EBITDA rose to $5.0 M for the year and $1.2 M for Q4, while net income turned positive at $1.1 M after a loss in 2024.
  • Completed first harvests from the newly acquired Cascadia indoor facility in February 2026; the combined production capacity now stands at ~15,500 kg across Pacifica and Cascadia.

Key Details

  • 2025 Financial Highlights
  • Net revenue: $59.5 M (↑22% YoY)
  • Gross profit before fair‑value adjustments: $19.5 M (↑27%)
  • Adjusted EBITDA: $5.0 M (↑25%)

  • Profit from operations: $1.8 M; Net income: $1.1 M

  • Q4 2025 Financial Highlights

  • Net revenue: $16.5 M (↑16% YoY)
  • Gross profit before fair‑value adjustments: $5.3 M (↑4%)

  • Adjusted EBITDA: $1.2 M

  • Operational Milestones

  • Cascadia facility rated capacity: 4,500 kg; first harvests completed 19 Feb 2026.
  • Combined annual production capacity of Pacifica + Cascadia: ~15,500 kg.

  • Anticipated GACP certification for Cascadia in coming months to support international medical market entry.

  • Market Position

  • 12 premium licensed producer in Canada (overall) and #12 premium vape brand (18.7% share).

  • 1964 Supply Co.™ ranked #12 premium brand; Wildflower™ holds #22 topical brand with 25.9% market share.

  • Financing Activity

  • Closed non‑brokered private placement: gross proceeds ≈ $4.5 M.

  • Secured a $3 M long‑term loan at 6.79% interest (5‑year term, 10‑year amortization).

  • Outlook for 2026

  • Expect revenue and Adjusted EBITDA growth driven by Cascadia ramp‑up; margin pressure anticipated in H1 due to capital outlays, with improvement in H2 as production commercializes.

  • Targeting international launch of 1964 Supply Co.™ brand and additional genetic releases (e.g., BC Organic Lemolada, Mandarin Zktz).

  • Conference Call – March 24 2026, 7:00 AM PT / 10:00 AM ET (details provided in release).

Notable Quotes

“In a milestone year, we delivered record revenues… Cascadia is now fully planted and early harvests are complete. We expect this expanded supply to support both domestic and international growth…” – Margaret Brodie, CEO

Read the original news release →

More from Rubicon Organics Inc.

Jun 04, 2026 · 07:00

Rubicon Organics Clinches Double Grow Up Award as Cascadia Ramp-Up Pressures Near-Term Margins

Other May 14, 2026 · 07:30

Rubicon Organics Q1 Revenue Grows, But EBITDA Loss Signals Ramp-Up Costs Weigh on Margins

Earnings May 11, 2026 · 07:00

Rubicon Organics Secures Export Certification Amidst Capacity Data Discrepancies and Temporary Liquidity

Production / Operations Apr 27, 2026 · 18:00

Rubicon Organics Secures Working Capital Amidst Cascadia Ramp-Up; UK Launch Awaits Revenue Confirmation

Financings Apr 12, 2026 · 20:00

Rubicon Organics Executes UK Expansion Plan Following Record Profitability

M&A / Property Feb 19, 2026 · 20:09

Rubicon Organics completes first Hope facility harvest

Production / Operations